As the entries deadline draws near, we’re excited to say that Elsevier are kindly providing access to their complete R&D solutions portfolio to our two winners, an essential set of tools to support the startups on their journey.

Elsevier’s R&D Solutions is a portfolio of tools that integrate data, analytics and technology capabilities to help pharmaceutical & life sciences customers make data-driven drug discovery and development decisions.  These tools help customers:

  • streamline target selection and biomarker identification
  • achieve more efficient hit identification and lead optimization
  • make more informed drug development decisions on safety and efficacy, risk assessments and mitigation, and study designs
  • find partnerships and identify key opinion leaders to stay on the cutting edge of developing research
  • and more ……

To find out more about Elsevier’s offerings go to